Work

860 Phase Iii Randomized Trial of Sunitinib Malate Versus Interferon-alfa as First-line Systemic Therapy for Patients With Metastatic Renal Cell Carcinoma

Year: 2007

Type: conference-abstract

Source: European Urology Supplements

DOI: 10.1016/s1569-9056(07)60855-0

Authors: O. Rixe, T.E. Hutson, P. Tomczak, M.D. Michaelson, R.M. Bukowski, S. Oudard, S. Negrier, S.T. Kim, I. Chen, R.A. Figlin, R.J. Motzer

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1982778812

Cites:

Cited by: 5

Related to: 10